It is the active ingredient behind well-known brands, such as Wegovy and Ozempic, used for both diabetes management and weight loss
For example, semaglutide 2.4mg (Wegovy) has demonstrated approximately 15% weight loss at 68 weeks in clinical trials, while liraglutide 3mg (Saxenda) typically achieves around 8% at 56 weeks
Yes, as it improves hydration and reduces dryness
That is very different from a drug actually causing a new cancer. When to stay away from GLP-1 drugs The teams findings should alleviate fears from patients and doctors about GLP-1s and thyroid cancer in general, the researchers say
In 2026, once-daily pill versions of Wegovy are expected to be available, and Ozempic tablets are expected soon
Sports drug testing using complementary matrices: Advantages and limitations